Review of Applications of High-Throughput Sequencing in Personalised Medicine: Barriers and Facilitators of Future Progress in Research and Clinical Application

G Lightbody, Valeriia Haberland, Browne Fiona, Laura Taggart, Huiru Zheng, Eileen Parks, Jaine Blayney

Research output: Contribution to journalReview article

Abstract

There has been an exponential growth in the performance and output of sequencing technologies (omics data) with full genome sequencing now producing gigabases of reads on a daily basis. This data may hold the promise of personalised medicine, leading to routinely-available sequencing tests that can guide patient treatment decisions. In the era of high-throughput sequencing, computational considerations, data governance and clinical translation are the greatest rate-limiting steps. To ensure that
the analysis, management and interpretation of such extensive omics data is exploited to its full potential, key factors including, sample sourcing, technology selection, and computational expertise and resources, need to be considered, leading to an integrated set of high-performance tools and systems.
This paper provides an up-to-date overview of the evolution of high-throughput
sequencing and the accompanying tools, infrastructure and data management
approaches that are emerging in this space, which, if used within in a multidisciplinary context, may ultimately facilitate the development of personalised medicine.
LanguageEnglish
Article numberbby051
Number of pages17
JournalBriefings in Bioinformatics
Early online date31 Jul 2018
DOIs
Publication statusE-pub ahead of print - 31 Jul 2018

Fingerprint

Precision Medicine
Clinical Governance
Technology
Research
Genome
Growth
Therapeutics

Keywords

  • high-throughput sequencing
  • personalised medicine
  • clinical translation
  • translational research
  • high-performance computing
  • grid computing
  • cloud computing

Cite this

@article{5f3e12a10d1342dd80d65fb75b26de25,
title = "Review of Applications of High-Throughput Sequencing in Personalised Medicine: Barriers and Facilitators of Future Progress in Research and Clinical Application",
abstract = "There has been an exponential growth in the performance and output of sequencing technologies (omics data) with full genome sequencing now producing gigabases of reads on a daily basis. This data may hold the promise of personalised medicine, leading to routinely-available sequencing tests that can guide patient treatment decisions. In the era of high-throughput sequencing, computational considerations, data governance and clinical translation are the greatest rate-limiting steps. To ensure thatthe analysis, management and interpretation of such extensive omics data is exploited to its full potential, key factors including, sample sourcing, technology selection, and computational expertise and resources, need to be considered, leading to an integrated set of high-performance tools and systems.This paper provides an up-to-date overview of the evolution of high-throughputsequencing and the accompanying tools, infrastructure and data managementapproaches that are emerging in this space, which, if used within in a multidisciplinary context, may ultimately facilitate the development of personalised medicine.",
keywords = "high-throughput sequencing, personalised medicine, clinical translation, translational research, high-performance computing, grid computing, cloud computing",
author = "G Lightbody and Valeriia Haberland and Browne Fiona and Laura Taggart and Huiru Zheng and Eileen Parks and Jaine Blayney",
year = "2018",
month = "7",
day = "31",
doi = "10.1093/bib/bby051",
language = "English",
journal = "Briefings in Bioinformatics",
issn = "1467-5463",

}

TY - JOUR

T1 - Review of Applications of High-Throughput Sequencing in Personalised Medicine: Barriers and Facilitators of Future Progress in Research and Clinical Application

AU - Lightbody, G

AU - Haberland, Valeriia

AU - Fiona, Browne

AU - Taggart, Laura

AU - Zheng, Huiru

AU - Parks, Eileen

AU - Blayney, Jaine

PY - 2018/7/31

Y1 - 2018/7/31

N2 - There has been an exponential growth in the performance and output of sequencing technologies (omics data) with full genome sequencing now producing gigabases of reads on a daily basis. This data may hold the promise of personalised medicine, leading to routinely-available sequencing tests that can guide patient treatment decisions. In the era of high-throughput sequencing, computational considerations, data governance and clinical translation are the greatest rate-limiting steps. To ensure thatthe analysis, management and interpretation of such extensive omics data is exploited to its full potential, key factors including, sample sourcing, technology selection, and computational expertise and resources, need to be considered, leading to an integrated set of high-performance tools and systems.This paper provides an up-to-date overview of the evolution of high-throughputsequencing and the accompanying tools, infrastructure and data managementapproaches that are emerging in this space, which, if used within in a multidisciplinary context, may ultimately facilitate the development of personalised medicine.

AB - There has been an exponential growth in the performance and output of sequencing technologies (omics data) with full genome sequencing now producing gigabases of reads on a daily basis. This data may hold the promise of personalised medicine, leading to routinely-available sequencing tests that can guide patient treatment decisions. In the era of high-throughput sequencing, computational considerations, data governance and clinical translation are the greatest rate-limiting steps. To ensure thatthe analysis, management and interpretation of such extensive omics data is exploited to its full potential, key factors including, sample sourcing, technology selection, and computational expertise and resources, need to be considered, leading to an integrated set of high-performance tools and systems.This paper provides an up-to-date overview of the evolution of high-throughputsequencing and the accompanying tools, infrastructure and data managementapproaches that are emerging in this space, which, if used within in a multidisciplinary context, may ultimately facilitate the development of personalised medicine.

KW - high-throughput sequencing

KW - personalised medicine

KW - clinical translation

KW - translational research

KW - high-performance computing

KW - grid computing

KW - cloud computing

UR - https://doi.org/10.1093/bib/bby051

U2 - 10.1093/bib/bby051

DO - 10.1093/bib/bby051

M3 - Review article

JO - Briefings in Bioinformatics

T2 - Briefings in Bioinformatics

JF - Briefings in Bioinformatics

SN - 1467-5463

M1 - bby051

ER -